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Adipose tissue is an essential regulator of metabolic
homeostasis. In contrast with white adipose tissue,
which stores excess energy in the form of triglycer-
ides, brown adipose tissue is thermogenic, dissi-
pating energy as heat via the unique expression
of the mitochondrial uncoupling protein UCP1. A
subset of UCP1+ adipocytes develops within white
adipose tissue in response to physiological stimuli;
however, the developmental origin of these ‘‘brite’’
or ‘‘beige’’ adipocytes is unclear. Here, we report
the identification of a BMP7-ROCK signaling axis
regulating beige adipocyte formation via control of
the G-actin-regulated transcriptional coactivator my-
ocardin-related transcription factor A, MRTFA.White
adipose tissue from MRTFA–/– mice contains more
multilocular adipocytes and expresses enhanced
levels of brown-selective proteins, including UCP1.
MRTFA–/– mice also show improved metabolic pro-
files and protection fromdiet-induced obesity and in-
sulin resistance. Our study hence unravels a central
pathway driving the development of physiologically
functional beige adipocytes.
INTRODUCTION
Adipose tissue is an essential regulator of metabolic homeosta-
sis and is composed of mesenchymal stem cells, vascular cells,
preadipocytes, and mature fat cells. At least two types of adipo-
cytes exist with distinct phenotypes and function. White adipo-
cytes are morphologically distinct from brown adipocytes and
store lipids in unilocular droplets. In comparison, brown adipo-
cytes contain multilocular lipid droplets and numerous mito-
chondria. Whereas white adipocytes store excess energy in
the form of triglycerides, brown adipocytes are thermogenic,
oxidative cells that, when activated by appropriate stimuli,
dissipate energy as heat (Cannon and Nedergaard, 2004).
Energy release is achieved due to the activity of UCP1, a brown
adipose tissue (BAT)-specific mitochondrial uncoupling protein
(Nedergaard et al., 2005). Because of its unique function,
enhancing BAT mass and/or activity is an attractive therapeuticapproach for individuals suffering from obesity and/or type 2
diabetes.
A distinct population of UCP1+ adipocytes develops within the
white adipose tissue (WAT) of mice in response to cold exposure
(Cousin et al., 1992, 1996; Guerra et al., 1998; Loncar, 1991a,
1991b), b3 adrenergic receptor (AR) agonist treatment (Collins
et al., 1997; Ghorbani and Himms-Hagen, 1997; Granneman
et al., 2005; Guerra et al., 1998; Nagase et al., 1996), PPARg
agonist administration (Petrovic et al., 2010; Vernochet et al.,
2009; Wilson-Fritch et al., 2004; Xue et al., 2005), or exposure
to FGF21, irisin, or cardiac natriuretic peptides (Bordicchia
et al., 2012; Bostro¨m et al., 2012; Fisher et al., 2012). The devel-
opmental origins of these cells designated ‘‘brite’’ or ‘‘beige’’ ad-
ipocytes, are not well understood (Enerba¨ck, 2009; Ishibashi and
Seale, 2010; Petrovic et al., 2010; Young et al., 1984). Current hy-
potheses propose that they arise from the conversion of existing
white adipocytes and/or the differentiation of WAT resident pro-
genitor cells (Himms-Hagen et al., 2000; Jimenez et al., 2003;
Lee et al., 2012; Long et al., 2014; Rosenwald et al., 2013;
Wang et al., 2013; Wu et al., 2012; Zingaretti et al., 2009). Line-
age tracing studies revealed that interscapular BAT arises from
the dermomyotome (Atit et al., 2006; Seale et al., 2008). Brown
and beige adipocytes in vitro possess a distinct gene expression
signature (Wu et al., 2012) suggesting divergent processes regu-
late prenatal development of classical BAT and postnatal forma-
tion of brite/beige adipocytes within WAT.
Discovering the origins of adipocyte progenitors is of intense
interest. A population of white adipocyte progenitors resident
in the adult WAT stroma were characterized by specific cell sur-
face markers (Rodeheffer et al., 2008). PPARg lineage tracing
studies indicated that WAT progenitors reside in the mural cell
compartment of adipose vasculature (Tang et al., 2008) and at
least a population of beige cells have a smoothmuscle-like origin
(Long et al., 2014). These observations suggest that white and
beige adipocytes arise from progenitors closely associated
with the vasculature. Physiological signals that regulate the
fate of these progenitors, and their tissues of origin have yet to
be determined.
Members of the TGFb superfamily are intimately involved in
the development and maintenance of the vasculature (Jakobs-
son and van Meeteren, 2013; Patel-Hett and D’Amore, 2011).
TGFb promotes smooth muscle differentiation and coordinates
the expression of SMC genes (Hautmann et al., 1997; Li et al.,
2012; Sinha et al., 2004; Wang et al., 2010). TGFb also inhibitsCell 160, 105–118, January 15, 2015 ª2015 Elsevier Inc. 105
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Figure 1. BMP7 and TGFb Mediate Distinct Effects on Lineage Commitment of MSCs through Alteration of ROCK Activity
(A) Differentiation protocol used for mesenchymal stem cells.
(B and C) Subconfluent C3H10T1/2 cells (B) or mouse bonemarrow-derivedMSCs (Life Technologies, GIBCO) (C) were exposed to BMP7 (6.3 nM) and/or TGFb1
(1 nM) for 3 days, then induced to differentiate without BMP7 or TGFb as in (A) Differentiation of cells was assessed by western blot (B) or phase contrast
microscopy (C).
(D and E) Western blot analysis of C3H10T1/2 cell proteins after a 10min exposure to vehicle, BMP7, TGFb, or BMP7 and TGFb (D) or BMP7 alone following a 2 hr
pretreatment with either 125 nM Gremlin1 or 200 nM Dorsmorphin homolog (DMH1) or 50 mM PD169316 (E).
(F) BonemarrowMSCswere induced to differentiate in response to BMP7 as in (A) in presence or absence of Gremlin1 and RNAwas subjected to qPCR analysis.
(G) Subconfluent C3H10T1/2 MSCs were exposed to TGFb1 (1 nM) alone or BMP7 (6.3 nM) with or without Gremlin1 for 48 hr, then stained with Alexa Fluor 488
phalloidin and visualized at 403 magnification.
(legend continued on next page)
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adipocyte differentiation via its coeffector, Smad3, which com-
plexes with C/EBPb and represses activation of adipogenic
target genes (Choy and Derynck, 2003). Interestingly, Smad3
knockout (KO) mice develop brown-like adipocytes in WAT de-
pots and are protected from obesity, illustrating the role of the
TGFb/Smad3 pathway in the negative regulation of browning
of WAT (Yadav et al., 2011).
In contrast with TGFb, bone morphogenetic proteins (BMPs),
promote adipocyte formation (Schulz and Tseng, 2009). Expo-
sure of multipotent MSCs to BMP2 or BMP4 gives rise to a
population of preadipocyte-like cells, which differentiate to
mature adipocytes (Ahrens et al., 1993; Bowers and Lane,
2007; Tang et al., 2004; Wang et al., 1993, 2009). BMP7 initiates
the commitment of MSCs to the brown adipocyte lineage
(Tseng et al., 2008) by promoting the expression of the brown
adipocyte factors PRDM16, PGC-1a and UCP1, and mitochon-
drial biogenesis (Tseng et al., 2008). Importantly, the absence of
BMP7 in mice attenuates the formation of BAT (Tseng et al.,
2008); BMP7 is also able to induce the conversion of progeni-
tors isolated from WAT, BAT, and muscle to brown-like adipo-
cytes (Schulz et al., 2011). BMP4 and BMP8b have also been
implicated in the browning of WAT and enhancing energy
expenditure and insulin sensitivity (Qian et al., 2013; Whittle
et al., 2012).
Additional downstream effectors of TGFb and BMPs include
members of the Rho-GTPase family, which mediate the dy-
namic control of monomeric and filamentous actin (Moustakas
and Heldin, 2008). Monomeric G-actin can regulate the nu-
cleus-cytoplasm shuttling of serum response factor (SRF) core-
gulators, myocardin-related transcription factors (MRTFs) and,
thereby, influence the expression of SRF target genes including
smooth muscle actin (SMA) (Miralles et al., 2003; Olson and
Nordheim, 2010). Several studies have reported on the involve-
ment of Rho-GTPase in regulating the fate of MSCs (McBeath
et al., 2004; Sordella et al., 2003), but there are no studies
of the potential role of MRTFs. Here, we identified a BMP7-
controlled signaling and transcriptional circuit involving MRTFA,
which enhances the development of beige adipocytes in WAT,
resulting in protection from diet-induced obesity and insulin
resistance.
RESULTS
BMP7 and TGFb1 Mediate Distinct Effects on Lineage
Commitment of MSCs
To investigate the effects of BMP7 and TGFb1 on lineage
commitment, subconfluent multipotent C3H/10T1/2 MSCs
were exposed to each effector for 3 days until reaching conflu-
ence and then exposed to a brown adipogenic cocktail
(illustrated in Figure 1A). As anticipated, BMP7-treated cells
developed into brown-like adipocytes, noted by elevated(H) Subconfluent C3H10T1/2 MSCs were exposed to BMP7 or TGFb with or with
were analyzed for phospho-MYPT1.
(I) Protein extracts from C3H10T1/2 MSCs at the indicated times of differentiatio
(J and K) Subconfluent, proliferating C3H10T1/2 MSCs were treated with Y276
analyzed by western blot (J) and immunofluorescence (K). Nonadjacent lanes on
See also Figure S1.expression of UCP1, PPARg, and Perilipin (Figure 1B). BMP7
also downregulated SMA in proliferating MSCs (Figure 1B).
MSCs exposed to TGFb1, however, failed to undergo adipogen-
esis but instead produced elevated levels of SMA, suggesting
the cells committed to a smooth muscle-like lineage. Exposure
to both BMP7 and TGFb1 resulted in a mixed population of
differentiated cells, as indicated by large numbers of fibroblastic
cells, and to a lesser extent, Oil Red O positive adipocytes (data
not shown). Heterogeneity of the population was confirmed by
the abundant expression of SMA and a low level of adipocyte
proteins (Figure 1B). To confirm that the effects of BMP7 and
TGFb were not unique to C3H/10T1/2 MSCs, these factors
also regulated the differentiation of bone marrow-derived
MSCs (Figure 1C).
We next analyzed the signaling pathways activated in
response to these effectors. As expected, TGFb1 in the pres-
ence or absence of BMP7 activated the phosphorylation
of SMAD2 and SMAD3. BMP7, however, stimulated the phos-
phorylation of SMADs 1/5/8, with negligible phosphorylation of
SMADs 2 or 3 (Figure 1D). Interestingly, TGFb1 also activated
SMADs 1/5/8 indicating that BMP7-induced commitment is not
mediated exclusively by activation of the SMADs, but by addi-
tional downstream effectors of the BMP receptor. In fact,
BMP7 activated p38MAPK signaling (Figure S1A), which was
required for BMP7-induced brown adipogenesis because treat-
ment of the MSCs with a p38MAPK inhibitor (PD169316) sup-
pressed UCP1 expression (Figure S1B). Inhibition of the BMP
type I receptors with dorsomorphin homolog (DMH1) or inhibition
of BMP7 directly with Gremlin1 (Hsu et al., 1998) attenuated the
activation of SMADs 1/5/8 and p38MAPK confirming that stimu-
lation of both pathways occurs through BMP7 and its receptor
(Figure 1E). Notably, DMH1 diminished C3H/10T1/2 MSCs dif-
ferentiation in a concentration-dependent manner (Figure S1C)
and Gremlin1 attenuated the differentiation of bone marrow-
derived MSCs in response to BMP7 (Figure 1F).
BMP7 Represses ROCK Activity and Alters Actin
Dynamics in MSCs
Cells exposed to BMP7 or TGFb1, exhibited marked changes in
morphology. BMP7-treated cells exhibited a broadened shape
and a less prominent actin network when compared to control
cells (Figure 1G). This phenomenon is controlled by BMP activity,
as it was reversed by coincubation with Gremlin1. TGFb1, in
contrast, promoted an elongated morphology and formation of
actin microfilaments. We hypothesized that these changes in
actin dynamics were mediated by Rho-associated protein ki-
nase (ROCK), a major effector of the RhoA pathway (Schofield
and Bernard, 2013). Following exposure of MSCs to BMP7,
ROCK activity was repressed below basal levels, as assessed
by a reduction in the phosphorylation of one of its targets,
MYPT1 (Figure 1H). In fact, BMP7 inhibited ROCK as effectivelyout Y27632 (10 mM) or CCG1423 (10 mM) for 2 hr at which stage protein lysates
n (as illustrated in A) were analyzed by western blot.
32 with or without BMP7 for 48 hr and levels of F-actin versus G-actin were
western blots (B, D, E, and H) are indicated by a vertical line.
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Figure 2. Inhibition of ROCK or SRF Activity
Promotes Commitment to the Adipogenic
Lineage
(A) C3H/10T1/2 cells were treated with the indi-
cated concentrations of Y27632 in the presence or
absence of BMP7 and induced to differentiate for
8 days and extracted proteins analyzed bywestern
blot.
(B) C3H/10T1/2 cells were treated with Gremlin1
and/or Y27632 2 hr prior to the addition of BMP7
or TGFb, as indicated. Following adipocyte
differentiation (day 8), total cellular proteins were
analyzed.
(C) C3H10T1/2 cells were exposed to either BMP7,
Y27632, or CCG1423 (10 mM) and actin filaments
were analyzed after 2 days as in Figure 1G (left
panels) or allowed to mature to adipocytes and
stained with Nile Red (right panels).
(D) Subconfluent C3H10T1/2 cells were treated
with either CCG1423 or BMP7 for 3 days prior to
induction of differentiation for 8 days, at which
stage cultures were visualized following Nile Red
staining.
(E) C3H/10T1/2 cells were treated with 1 mM or
10 mMCCG1423, or BMP7 for 3 days and induced
to differentiate. Total RNAwas subjected to q-PCR
analysis. Nonadjacent lanes on western blots in (A)
are indicated by a vertical line.
See also Figure S2.as the ROCK-specific inhibitor, Y27632. As expected, TGFb1
strongly induced MYPT1 phosphorylation, which was only
partially inhibited by a dose of Y27632 that was sufficient to
block endogenous TGFb1 activity. Importantly, ROCK activity
declined rapidly during BMP7-induced brown adipogenesis
reaching undetectable levels in mature adipocytes (Figure 1I).
Coincident with modulation of the RhoA pathway are changes
in the relative amounts of G-actin and F-actin. Consistent with its
inhibition of ROCK, biochemical and cell staining assays re-
vealed that BMP7 increased the G/F-actin ratio (Figures 1J and
1K). The ROCK inhibitor Y27632 similarly enhanced G-actin
levels relative to F-actin (Figure 1J).
Inhibition of the ROCK/SRF Pathway Enhances Brown
Adipogenesis in MSCs
The proadipogenic properties of BMP7 closely correlated with
inhibition of ROCK activity, which led us to question whether108 Cell 160, 105–118, January 15, 2015 ª2015 Elsevier Inc.Y27632 could mimic the effects of
BMP7. Although, Y27632 alone had a
modest effect on adipocyte gene expres-
sion (Figure 2A) and on the number of
cells converting to Nile Red-positive adi-
pocytes (Figure 2C), it did potentiate the
action of BMP7 as revealed by enhanced
expression of PPARg and FABP4 (Fig-
ure 2A). ROCK inhibition did not alter
BMP7-induced UCP1 expression. Inter-
estingly, ROCK inhibition partially over-
came the inhibitory effect of Gremlin on
adipocyte gene expression (Figure 2B,compare lanes 3 and 4) and differentiation (Figure S2) while
having limited effects on UCP1 expression.
Cytoplasmic G-actin regulates SRF activity by associating
with or dissociating from its coregulators, MRTFs (Posern and
Treisman, 2006). When effectors activate ROCK and drive G-
actin into filamentous actin (F-actin), MRTFs translocate to the
nucleus and promote transcription of SRF-target genes (Olson
and Nordheim, 2010). Because BMP7 inhibits ROCK, we ques-
tioned whether its proadipogenic activity involves suppression
of MRTF/SRF activity. In fact, exposure of MSCs to CCG1423
(an inhibitor of SRF activity) (Evelyn et al., 2007) prior to stimula-
tion of adipogenesis enhanced their conversion to adipocytes
(Figures 2C and 2D) while inducing expression of brown adipo-
cyte genes (Figure 2E). Importantly, unlike Y27632, CCG1423
did not alter the actin cytoskeleton, (Figure 2C, phalloidin stained
cells) indicating that it blocks SRF downstream of F-actin
polymerization.
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Figure 3. MRTFA and SRF Overexpression Prevent Differentiation of MSCs to Adipocytes
(A and B) qPCR and western blot analysis of indicated mRNAs (A) and proteins (B) in C3H/10T1/2 MSCs undergoing brown adipogenesis.
(C) C3H/10T1/2 cell lines ectopically expressing SRF or MRTFA were induced to differentiate then visualized by phase contrast microscopy.
(D and E) The cell lines (C) were differentiated in absence (D) or presence (E) of BMP7 and isolated RNA subjected to qPCR analysis.
See also Figure S3.Genetic Manipulation of MRTFA-SRF Transcriptional
Activity Regulates Commitment of MSCs to an
Adipogenic Lineage
Our observation that CCG1423 could mimic BMP7 suggests
that MRTF/SRF antagonizes the commitment of MSCs to
an adipogenic lineage. Other studies have identified SRF as
an inhibitor of adipogenesis in 3T3-L1 preadipocytes (Mikkelsen
et al., 2010), but little is known about its role in regulating thefate of MSCs. Using C3H/10T1/2 MSCs, adipogenesis was
accompanied by a decrease in MRTFA, MRTFB, SRF, and
select SRF target genes, SMA, collagen 1a1, and collagen
3a1 (Figures 3A and 3B). The lower band in Figure 3B corre-
sponds to SRF (Figure S3A). Cell lines were generated to ectop-
ically express SRF or MRTFA (Luchsinger et al., 2011; Wang
et al., 2012a), which resulted in reduced conversion of the
MSCs to adipocytes (Figure 3C) and inhibited expression ofCell 160, 105–118, January 15, 2015 ª2015 Elsevier Inc. 109
select white and brown adipogenic genes (Figures 3D and 3E).
In addition, treatment with CCG1423 partially rescued the
inhibitory effect of MRTFA or SRF on adipocyte formation (Fig-
ure S3B). Together, these results demonstrate that the ROCK-
SRF pathway is an important BMP7 target and its repression
facilitates adipogenesis.
Increased Production of Beige Adipocytes in WAT of
MRTFA-Deficient Mice
To investigate the potential role of MRTFA/SRF in adipose devel-
opment in vivo, we analyzed different adipose tissues in MRTFA-
deficient mice (Li et al., 2006) and observed dramatic increases
in multilocular adipocytes (Figure S4B) within the subcutaneous
(inguinal, iWAT) fat depot of these mice compared to their wild-
type (WT) littermates (Figure 4A). The epididymal (eWAT) depot
of the KO mouse had few multilocular cells, but the size of the
adipocytes in this depot was smaller than in the corresponding
depot of WT littermates. Immunohistochemical staining of
multiple tissue sections demonstrated that the multilocular adi-
pocytes in the iWAT express UCP1 in mice maintained at room
temperature, suggesting that MRTFA deficiency alters an early
developmental pathway (Figure 4A). We did not detect any
morphological or UCP1 expression changes in the BAT of KO
mice. With maturation, iWAT fromWTmice underwent hypertro-
phy leading to an increase in the size of individual unilocular
adipocytes (Figure S4A). In contrast to WT mice, the iWAT of
MRTFA–/– mice consisted of more multilocular cells and the
extent of hypertrophy with age was less pronounced (Fig-
ure S4A). Body weight also correlated with the differences in
depot morphology. MRTFA–/– mice gained less weight during
6 weeks of low fat diet and contained less overall fat mass rela-
tive to lean mass when compared toWT littermates (Figures 4B–
4D andS4C). MRTFA-deficient mice also had lower fasting levels
of glucose thanWTmice but therewere no differences in glucose
measured during a GTT (Figures S4D and S4E). MRTFA–/– mice
also produced lower circulating levels of leptin and higher levels
of adiponectin and insulin (Figure S4F).
RNA analysis revealed that iWAT from MRTFA–/– mice ex-
presses 30-fold more UCP1 mRNA relative to WT littermates
(Figure 4E). No significant difference in UCP1 mRNA levels in
BAT of WT and KO mice were observed, although the relative
amount of UCP1 mRNA in BAT was significantly higher than in
iWAT of WT littermates. Expression of other brown adipocyte
mRNAs (Fabp3, Cox7a1, Elovl3, and Cox8b) were similarly
higher in the iWAT of MRTFA–/– mice compared to WT litter-
mates. Our previous studies identified genes that are abundantly
expressed inWAT relative to BAT (Vernochet et al., 2009). Impor-
tantly, one of these genes, angiotensinogen (Agt), is expressed
at much lower levels inMRTFA–/– iWAT relative to WT iWAT (Fig-
ure 4E), consistent with the enhanced development of brown-
like adipocytes within iWAT of KO mice. Expression of SMA
was also reduced inMRTFA–/– iWAT compared to theWT depot.
The transcription factor Tbx1 has recently been assigned as a
marker of beige adipocytes (Wu et al., 2012). Importantly, Tbx1
expression was significantly higher inMRTFA–/– iWAT compared
to WT iWAT (Figure 4E) suggesting that the appearance of UCP1
positive, multilocular adipocytes inMRTFA–/– mice is likely due to
recruitment of beige progenitors.110 Cell 160, 105–118, January 15, 2015 ª2015 Elsevier Inc.Stromal Vascular Cells from MRTFA–/– iWAT Undergo
Beige Adipogenesis More Extensively Than WT SVF
Cells
Because the mice used in this study were a total body knockout,
we examined whether MRTFA represses beige adipocyte forma-
tion directly. Stromal vascular cells (SVFs) of WT and KO iWAT
differentiated into adipocytes in vitro to approximately the
same extent as judged by comparable expression of adiponec-
tin, adipsin, and FABP4 (Figure 5A). MRTFA–/– SVFs, however,
expressed higher amounts of select BAT proteins including
UCP1 and Chchd10/NDG2 (Figure 5A). Treatment of the adipo-
cytes with forskolin (FSK) for 4 hr dramatically induced expres-
sion of UCP1 mRNA in both WT and KO cells when normalized
to basal untreated levels (Figure 5B). The FSK-dependent
induction of UCP1, Fabp3, Cidea, Cox7a1, and Elovl3 were
significantly higher in KO versus WT adipocytes (Figure 5B).
The induction of PGC-1a mRNA, however, was similar in both
WT and KO cells. A recent study suggested that some beige
adipocytes have a smooth muscle-like origin; therefore, we
analyzed expression of SM genes during early adipogenesis
in SVF cells (Long et al., 2014). Treatment of cells with BMP7
for 48 hr resulted in a significant decrease in MRTFA, CRP2,
SMA, and calponin expression (Figure 5C). In contrast, TGFb1
enhanced SM protein expression (Figures 5C and 5D). In addi-
tion, the KO SVF cells expressed significantly lower amounts
of the SM proteins under all conditions compared to WT cells
(Figure 5D). These data suggest that BMP7 directs SVF progen-
itors to a beige adipocyte lineage rather than a SM lineage.
Treatment of mice with a b-adrenoceptor agonist such as
CL316,243 results in ‘‘browning’’ of iWAT characterized by
enhanced UCP1 expression and appearance of beige/brite
adipocytes (Cousin et al., 1992; Barbatelli et al., 2010; Wu
et al., 2012). We questioned, therefore, whether MRTFA–/–
mice respond differently to b-adrenergic stimulation than WT
counterparts. Consistent with the earlier observations (Cousin
et al., 1992), we show that WT mice induce browning of WAT
depots based on more intense UCP1 staining in response to
CL316,243 (Figure 6A). Importantly, MRTFA–/– mice exhibited
an enhanced response to CL316,243 than their WT littermates
by producing larger regions of UCP1 positive multilocular adipo-
cytes in iWAT (Figure 6A) and expressed higher amounts of
select brown genes UCP1, Elovl3, Fabp3, Cidea, and Cox7a1
(Figure 6B) and UCP1 protein (Figure 6C).
MRTFA-Deficient Mice Are Protected fromDiet-Induced
Obesity and Insulin Resistance
Mice were fed a high-fat diet (HFD, fat 60 kcal%, 20 kcal% car-
bohydrate, protein 20 kcal%) for 6 weeks starting at 6 weeks of
age.MRTFA–/– mice gained less weight on the HFD compared to
the WT littermates (Figure 7A). Body composition analysis re-
vealed that KO mice gained less fat mass without any major
change in lean mass or food intake (Figure S5B). The iWAT and
eWAT of KO mice weighed less than corresponding depots in
control littermates while there was no significant change in
weight of BAT (Figure 7B). The weight of the liver in KO mice
fed a HFD for 6 weeks was much lower than in WT littermates
(Figure 7B). This difference in weight was likely due to the exten-
sive accumulation of hepatic lipid in WT mice (Figure S5C).
WT
10
40
200
300 Ucp1
0
*
20
30
BAT ING EPI
m
R
N
A 
(fo
ld 
ch
an
ge
)
m
R
N
A 
(fo
ld 
ch
an
ge
)
100
5
10
50
0
Fabp3
*
BAT ING EPI
20
40
1
3
0
Cox7a1
2
*
BAT ING EPI
200
100
800
0
20
40
60
80
Elovl3
*
BAT ING EPI
1
3
5
0
Cox8b
2
15
BAT ING EPI
0
1
2
3
4
5
6
Tbx1
**
BAT ING EPI
Pgc1a
0
1
2
3
4
5
6
7
8
9
10
BAT ING EPI
Mrtfa
0
0.2
0.6
1.0
1.2
1.4
*
0.4
1.6
0.8
BAT ING EPI
Sma
0
1.2
*
0.4
1.6
2.0
0.8
BAT ING EPI
Pank3
0
0.2
0.6
1.0
1.2
1.4
0.4
0.8
BAT ING EPI
Chemerin
0
0.2
0.6
1.0
1.2
1.4
0.4
0.8
BAT ING EPI
0.25
0.75
Agt
0
0.5
1.0
4.0
6.0
**
BAT ING EPI
E
A
W
T
H&E
ING EPI BAT 
ING EPI BAT 
UCP-1
B
C
1.0
1.4
1.8
W
ei
gh
t G
ai
n 
(g/
we
ek
)
WTKO
WTKO
6
8
10
12
*
Fa
t M
as
s 
(g)
WTKO
*
10
15
20
25
Le
an
 M
as
s 
(g)
ING 
EPI 
WT KO
W
T
D
Weeks on Diet
WT
20
25
30
35
0 2 4 6
Bo
dy
W
e
igh
t(g
)
Figure 4. MRTFA Deficiency in Mice Enhances Recruitment of Beige Adipocytes to the White Adipose Depots
(A) H&E and UCP1 staining of representative sections (n = 7) of ING (Inguinal) WAT, EPI (Epididymal) WAT and BAT from 11- to 13-week-old WT and MRTFA–/–
(KO) mice on rodent diet with 10% kcal% fat.
(B) Body weight and average weight gain per week of WT and MRTFA–/– mice on rodent diet with 10% kcal% fat (n = 5/group, *p < 0.05).
(C) Body composition determined by NMR (described in Experimental Procedures) analysis of mice from (B). Data presentedmean ±SEM, n = 5/group, *p < 0.05.
(D) Gross morphology of representative ING and EPI fat pads of mice from (B).
(E) Relative mRNA levels of BAT- and WAT-enriched genes as well as other genes in WAT and BAT depots of 15- week-old WT andMRTFA–/– mice on chow diet
was analyzed by qPCR. Data presented mean ± SEM, n = 4/group, *p < 0.05, **p < 0.01.
See also Figure S4.
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Figure 5. Cells from the Stromal Vascular Fraction ofMRTFA–/– ING
WAT Express Less Smooth Muscle-like Features and Undergo
Brown Adipogenesis More Extensively Than WT SVF Cells
(A) Western blot analysis on BAT- and WAT-enriched proteins of adipocytes
arising from hormonal induction of stromal vascular fractions (SVCs) isolated
from WT and MRTFA–/– inguinal depots.
(B) WT and MRTFA–/– SVC adipocytes were treated with or without forskolin
(FSK) for 4 hr prior to isolation of total RNA for analysis. Values are presented
as fold change in response to treatment with FSK in WT and MRTFA–/–
adipocytes.
(C and D) Subconfluent SVCs from ING and EPI WAT of WT and/orMRTFA–/–
mice were exposed to TGFb1 or BMP7 for 2 days before reaching confluence
and subjected to western blot analysis.MRTFA–/– mice had significantly lower levels of fasting glucose
and exhibited enhanced glucose tolerance compared to WT lit-
termates (Figures 7C and S5A). Additionally, KO mice had lower
circulating levels of leptin (Figure S5D) consistent with them
having less fat as well as higher circulating levels of adiponectin
(Figure S5D). The high-fat diet also resulted in hypertrophy of
individual adipocytes in the iWAT and eWAT of WT mice (Fig-
ure 7D). The corresponding depots in the KO mice showed no
sign of excess lipid deposition and the iWAT still produced abun-
dant amounts of UCP1 as well as other brown genes (Figures 7D
and 7E). Importantly, KOmice were protected from diet-induced
inflammation as observed by a reduction in crown-like structures
in the eWAT when compared to WT littermates (Figure 7D).
Taken together, these results indicate that MRTFA deficiency
reduces HFD-induced obesity, insulin resistance, eWAT inflam-
mation, and hepatic steatosis.
MRTFA Regulates Whole-Body Energy Expenditure
Indirect calorimetry analysis of mice following 6 weeks on high
or low fat diets demonstrated that KO mice produced more
heat and consumed more oxygen and carbon dioxide (Figures
7F and 7G) without any change in food intake or physical activity
compared to WT animals (Figure S6). Measurement of respira-112 Cell 160, 105–118, January 15, 2015 ª2015 Elsevier Inc.tory exchange ratio (RER) following the 6 weeks on LFD revealed
that KO mice expended significantly larger amounts of carbohy-
drate thanWTmice during the dark period with both sets of mice
switching equally to fat expenditure during the day light (Fig-
ure 7G). As expected, KO and WT mice metabolized predomi-
nantly fat throughout the entire night-day-night period on HFD
(Figure 7G).
DISCUSSION
There is an urgent need for effective and safe therapeutics
to address the complications arising from excessive adipose tis-
sue expansion. Most antiobesity drugs presently available have
serious side effects including depression and gastrointestinal
maladies (Kang and Park, 2012). Similarly, several of the drugs
that treat insulin resistance, type 2 diabetes, and cardiovascular
disease, either have life threatening side effects or are minimally
effective (Ahmadian et al., 2013; Stein et al., 2013). With the dis-
covery that humans possessmetabolically active brown adipose
tissue (van der Lans et al., 2013), it has been suggested that
increasing BAT mass and/or activity might be an effective anti-
obesity therapy (Farmer, 2009). We report here on the identifica-
tion of a signaling and transcriptional regulatory pathway that,
when inhibited in mice, leads to ‘‘beigeing’’ of iWAT and protec-
tion against diet-induced obesity and insulin resistance.
Various aspects of cell morphology control adipocyte differen-
tiation (Rodrı´guez Ferna´ndez and Ben-Ze’ev, 1989; Spiegelman
and Farmer, 1982; Spiegelman and Ginty, 1983). It has recently
been shown that cell shape regulates commitment of human
MSCs to an adipocyte or osteoblast fate via modulation of
RhoA signaling (McBeath et al., 2004). Specifically, dominant-
negative RhoA committed hMSCs to the adipogenic lineage,
while constitutively active RhoA favored the osteogenic lineage.
Our work demonstrates a role for RhoA signaling in controlling
the fate of MSCs to an adipogenic versus smooth muscle-like
lineage. Furthermore, we demonstrate that BMP7, in contrast
to TGFb suppresses ROCK and MRTFA/SRF activity, facilitating
commitment to the adipocyte lineage. The mechanisms by
which TGFb family members control ROCK are still poorly under-
stood. In other developmental systems, BMPs activate ROCK
and BMP2 for example stimulates osteogenesis in hMSCs
via ROCK-activated changes in cytoskeletal tension (Wang
et al., 2012c). In fact, our report is one of very few documenting
a BMP-associated suppression of the ROCK-actin-MRTFA
signaling pathway. One potential mechanism for the suppression
is a BMP-mediated inhibition of basal TGFb1 activity, as recently
reported for control of cardiac fibrosis (Wang et al., 2012b).
Modulation of MRTFA in MSCs highlights its role in regulating
BMP7-induced adipocyte formation, but this does not neces-
sarily exclude the participation of other actin-responsive tran-
scription factors, including MRTFB. The inhibitory action of
MRTFA appears to be mediated by its coactivation of SRF
because ectopic expression of SRF also attenuates the adipo-
genic action of BMP7. Studies byMikkelsen et al. (2010) showed
that SRF inhibited the differentiation of 3T3-L1 preadipocytes
and recently others demonstrated that MKL1 (MRTFA) blocks
3T3-L1 adipogenesis at a step upstream of PPARg (Nobusue
et al., 2014). The precise mechanism by which SRF controls
AB
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Figure 6. MRTFA–/– Mice Are Highly
Responsive to b-Adrenergic Signaling,
which Enhances Beige Adipocyte Forma-
tion in ING WAT
(A) UCP1 immunohistochemistry of representative
sections of BAT, ING, and EPI depots of WT and
MRTFA–/– mice following daily intraperitoneal (i.p.)
injections of 1 mg/kg CL316,243 or saline for
7 days.
(B and C) mRNA and protein levels of BAT- and
WAT-enriched genes as well as other genes in ING
WAT of WT and MRTFA–/– mice treated with or
without CL316,243 were determined by qPCR (B)
and western blot (C), respectively. Data presented
mean ± SEM, n = 4, *p < 0.05, **p < 0.01.adipogenic commitment might not involve a single target gene/
protein but expression of an entire program of genes coding
for extracellular matrix and cytoskeleton. Such a process would
facilitate extensive cell spreading, which is known to attenuate
adipocyte formation (Spiegelman and Ginty, 1983).
The appearance of UCP1+ adipocytes in iWAT of KO mice
suggests a role for suppression of MRTF/SRF activity in the
development of beige adipocytes. Other studies have demon-
strated that disruption of TGFb signaling in mice similarly en-
hances beige adipocyte formation in WAT (Yadav et al., 2011).
The MRTFA-associated browning of iWAT likely arises through
recruitment of beige progenitors, as opposed to transdifferentia-
tion of mature white adipocytes (Barbatelli et al., 2010; Wu et al.,
2012, 2013). In fact, iWAT of KOmice express high levels of Tbx1
(Figure 4E), supporting a mechanism of de novo generation of
beige adipocytes.
Formation of beige adipocytes could arise from crosstalk be-
tween adipose and other organs because MRTFA is absent in allCell 160, 105–118tissues of the knockout mouse (Li et al.,
2006). Interestingly, recent studies have
shown a role for BMP signaling in regu-
lating adipose formation through central
as well as peripheral actions (Townsend
et al., 2012; Whittle et al., 2012). The cen-
tral actions of the BMPs, however,
involve pathways other than the ROCK-
MRTFA axis (Townsend et al., 2012;
Whittle et al., 2012). Consistent with the
action of MRTFA being an autonomous
process, cells derived from the SVF of
KO iWAT differentiate to beige adipo-
cytes more robustly than WT cells (Fig-
ure 5). This could be due to expansion
of a pool of beige progenitors in the
vascular compartment of MRTFA–/–
iWAT from various sources including
pericytes and/or endothelial cells. In
fact, a small set of capillary endothelial
cells express the adipogenic commit-
ment factor ZFP423, suggesting a contri-
bution of specialized endothelial cells to
the adipose lineage (Gupta et al., 2010,2012). Furthermore, lineage tracing studies identified vascular
endothelial cells as progenitors of both white and brown adipo-
cytes (Tran et al., 2012). Such endothelial progenitors would
need to undergo endothelial-mesenchymal transition (End-MT)
prior to further adipogenic differentiation. In fact, BMP/TGFb
signaling has been linked to End-MT (Maddaluno et al., 2013;
Zeisberg et al., 2007), raising the possibility that MRTFA could
be functioning at such an early stage of adipogenic lineage
commitment.
Until recently, it was difficult to establish a role for beige adipo-
cytes in controlling energy expenditure (EE) from the dominant
role played by BAT. In fact, Shabalina et al. (2013) have argued
that brite/beige adipocytes have a minimal contribution to EE
because the level of UCP1 expression in these cells is too low.
Cohen et al. (2014) have demonstrated that absence of beige
adipocyte development in mice leads to DIO and insulin resis-
tance without any detectable change in BAT development or ac-
tivity; highlighting the potential importance of beige adipose in, January 15, 2015 ª2015 Elsevier Inc. 113
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energy balance. Our findings support the concept that beige
adipocytes perform a physiological role because lack of MRTFA
facilitated beige cell development without any significant effect
on BAT activity based on minimal change in BAT mass,
morphology, or UCP1 expression (Figure 4).
Our studies have uncovered a regulatory pathway that atten-
uates the antiadipogenic activity of MRTFA/SRF leading prefer-
entially to beige adipocyte formation in iWAT. We suggest that
this pathway directs the commitment of adipose stroma pro-
genitors to beige adipocyte over vascular lineages. Small mole-
cules that suppress MRTFA/SRF activity might lead to the
development of effective therapeutics to combat obesity-asso-
ciated comorbidities.
EXPERIMENTAL PROCEDURES
Animals
MRTFA+/– mice (mixed C57BL/6J 129 genetic background) were a gift fromDr.
Eric Olson, UT Southwestern Medical Center (Li et al., 2006). Mice were
housed at 23C in a 12 hr light/dark cycle with free access to normal chow.
All experiments used matched littermates. Experimental procedures were
approved by the Boston University Institutional Animal Care and Use
Committee.
High-Fat Feeding and b-Adrenergic Stimulation
For diet studies, 4- to 6-week-old male WT andMRTFA–/– mice were fed a diet
with 10% kcal% fat (low fat diet, Research Diets, D12450B) or diet with 60%
kcal% fat (high-fat diet, ResearchDiets, D12492) for 6 weeks. For b-adrenergic
stimulation, 14-week-old male WT and MRTFA–/– mice were intraperitoneally
(i.p.) injected daily for 7 days with 1 mg/kg CL316,243 (Sigma-Aldrich) or
vehicle.
Histology
Fat pads were fixed in 10% formalin, paraffin-embedded, and sectioned (7 mm)
prior to hematoxylin and eosin (H&E) staining or immunohistochemistry for
UCP1 (Abcam; 1:100). Signal was detected using the Vector ABC Elite kit.
Indirect Calorimetry and Body Composition
Animals were individually housed in metabolic chambers maintained at
20C–24C on a 12-hr light/12 hr dark cycle. Heat, VO2, VCO2, and RER
were measured continuously using CLAMS consisting of open circuit calorim-
eter and motion detectors. Body composition was measured by noninvasive
quantitative MRI (EchoMRI700).
Glucose Tolerance Tests
Mice were fasted for 14 hr then blood glucose was measured (Bayer Contour)
by tail bleeding at 0, 15, 30, 60, and 120 min after an injection of glucose
(2 mg/kg body weight).Figure 7. MRTFA-Deficient Mice Are Protected from Diet-Induced O
Whole-Body Energy Expenditure
(A and B) WT and MRTFA–/– mice, starting from 4- to 5-week-old, were fed a r
measured in weekly intervals (A), while weights of ING WAT, EPI WAT, BAT, and
(C) After 5 weeks on the HFD, mice were then i.p. injected with glucose at 2 mg/kg
at 15, 30, 60, and 120 min.
(D) H&E and UCP1 staining of sections of ING, EPI, and BAT depots.
(E) Western blot analysis of BAT- and WAT-enriched genes as well as other gen
Figure 4. Arrows point to crown-like structures. Data presented are mean ± SEM
(F andG)WT andMRTFA–/– mice on LFD or HFD for 6 weeks were housed individu
and CO2 production were measured by CLAMs (F). Traces of heat production, CO
cycles (G). Respiratory exchange ratio (RER) were calculated by volume of car
presented are mean ± SEM, n = 5–7/group, *p < 0.05.
See also Figures S5 and S6.Serum Leptin and Adiponectin
Mice were euthanized, and serum, obtained from heart blood using serum
separation tubes (BD), was analyzed using mouse leptin (Millipore EMD) and
total and HMW adiponectin mouse adiponectin (ALPCO) ELISA kits.
Adipose Tissue Fractionation and Culture of Stromal Vascular Cells
Inguinal fat pads were dissected from male mice, digested in collagenase,
filtered through a 100 mm mesh, and centrifuged at 500 3 g to isolate stromal
vascular cells for differentiation as outlined for C3H/10T1/2 cells stated below.
Cell Culture
Preconfluent C3H/10T1/2 cells (ATCC) were treated with 6.3 nM rhBMP7 or
1 nM rhTGFb1 (R&D Systems) for 3 days. The confluent cells were induced to
differentiate in 10% FBS, 5 mM dexamethasone, 0.5 mM isobutylmethylxan-
thine, 860 nM insulin, 1 nM 3,3,5-triiodo-L-thyronine (T3), and 125 mM indo-
methacin. Two days after induction, cells weremaintained in 10%FBS, insulin,
and T3 for 6 days. Cells were treated with recombinant Gremlin1 (R&D) and the
small molecule inhibitors Y27632, PD169316, SB341542 (Sigma), DMH1 (Toc-
ris), or CCG1423 (Cayman) as described in the legends of Figures 1 and 2.
Mouse bone marrow-derived MSCs were obtained from Life Technologies.
Plasmids and Viruses
MRTFA and SRF cDNAs (Chang et al., 2003; Luchsinger et al., 2011) were
subcloned into the pMSCV retroviral vector and packaged using EcoPack cells
(Clontech). Cells were incubated with viral supernatants supplemented with
10 mg/ml polybrene and selected with hygromycin.
Gene Expression Analysis
Total RNAwas isolated from cells or tissues using TRIzol reagent (Life Technol-
ogies). Gene expression was performed using an AppliedBiosystems cDNA kit
and Maxima SYBR Green qPCR Master Mix (Fermentas) as described (Pino
et al., 2012). Primer sequences are provided in Table S1.
Western Blot Analysis
Total cellular protein was extracted and subjected to western blot analysis as
described (Vernochet et al., 2009) using antibodies listed in Table S2.
Oil Red O and Nile Red Staining
Oil Red O staining was as described (Vernochet et al., 2010). Coverslips were
stained with Nile Red for 20 min at room temperature.
Phalloidin/DNase I Staining
Cells on gelatin-coated coverslips were fixed in formaldehyde, permeabilized
and stained in Alexa Fluor 488 Phalloidin and/or Deoxyribonuclease I Alexa
Fluor 594 (Molecular Probes).
G-Actin/Factin Assay
Relative G-actin/F-actin ratio was assessed using the G-actin/F-actin assay
kit (Cytoskeleton) according to the manufacturer’s directions with minor
modifications.besity and Its Associated Insulin Resistance and Exhibit Altered
odent HFD (60% kcal% fat) for 6 weeks. Body weight and weight gain were
liver were measured at end of study (B).
of body weight after fasting overnight and whole-blood glucose wasmeasured
es in WAT and BAT depots of WT and MRTFA–/– mice were conducted as in
, n = 6–7/group, *p < 0.05, **p < 0.01.
ally inmetabolic chambers for 3 days and 2 nights. Cumulative O2 consumption
2 production, and respiratory exchange ratio (RER) during 12 hr dark and light
bon dioxide produced (exhaled)/volume of oxygen consumed (inhaled). Data
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Statistical Analysis
Results are presented asmean ±SEM. Statistical differences were determined
by a Student’s two-tailed t test with equal variance or paired. Significance was
considered as p% 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and two tables can be found
with this article online at http://dx.doi.org/10.1016/j.cell.2014.12.005.
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